Emergency Indications for Vitamin B6 (Pyridoxine)
In emergency settings, vitamin B6 (pyridoxine) is primarily indicated for isoniazid overdose (1g pyridoxine IV for each gram of isoniazid ingested, up to 5g maximum) and ethylene glycol poisoning (50mg IV every 6 hours). 1, 2
Primary Emergency Indications
1. Isoniazid (INH) Overdose
- Dosing protocol: 1g pyridoxine IV for each gram of isoniazid ingested, then 1g IV/IM every 30 minutes up to a maximum of 5g 1, 2
- Clinical presentation: Refractory seizures, profound metabolic acidosis, coma (typically appearing 30 minutes to 2 hours after ingestion) 3
- Mechanism: Pyridoxine directly counteracts isoniazid's inhibition of GABA synthesis, which is responsible for the seizures
- Urgency: Immediate administration is critical as seizures may be refractory to standard anticonvulsants 3
2. Ethylene Glycol Poisoning
- Dosing protocol: 50mg IV every 6 hours 1, 2
- Mechanism: Helps in the metabolism of glycolic acid, reducing toxicity
- Administration: Should be given alongside definitive treatments (fomepizole or ethanol, hemodialysis)
3. Pyridoxine-Dependent Epilepsy
- Presentation: Rare autosomal recessive epileptic encephalopathy caused by antiquitin deficiency 1
- Treatment: May require very high doses for seizure control
- Note: This is a rare emergency indication but critical when encountered
Secondary Emergency Indications
1. Drug-Induced Deficiency
- FDA-approved indication: Treatment of drug-induced vitamin B6 deficiency 4
- Common culprits: Isoniazid therapy (preventative dose: 25-50mg/day, increased to 100mg/day if neuropathy develops) 2, 5
- Other medications: Penicillamine, anti-cancer drugs, corticosteroids, anticonvulsants 1
2. Acute Deficiency States
- High-risk populations: Alcoholics, renal dialysis patients (especially those on continuous renal replacement therapy), critically ill patients 1
- Dosing: 50-100mg IV/IM when oral administration is not feasible 4
- Indications: When gastrointestinal absorption is impaired or in pre/post-operative conditions 4
Clinical Pearls and Pitfalls
- Diagnostic measurement: Plasma pyridoxal phosphate (PLP) is the preferred biomarker; in critically ill patients or those with inflammation, red cell PLP should be measured instead 1, 2
- Toxicity concerns: Long-term doses as low as 100mg/day have been associated with sensory neuropathy; the No Observed Adverse Effect Level (NOAEL) is 100mg/day 1, 6
- Response timeline: When treating deficiency, PLP levels plateau in 6-10 days 1
- Administration route: Parenteral administration is indicated when oral administration is not feasible due to anorexia, nausea, vomiting, or impaired gastrointestinal absorption 4
Dosing in Nutritional Support
- Enteral nutrition: Should deliver at least 1.5mg pyridoxine per 1500 kcal 1
- Parenteral nutrition: Should deliver 4-6mg pyridoxine per day 1
Remember that vitamin B6 toxicity can occur with prolonged high-dose supplementation, presenting as sensory neuropathy with ataxia or areflexia, so emergency dosing should be followed by appropriate dose adjustments for maintenance therapy when indicated.